Escitalopram in obsessive-compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study

Dan J Stein, Elisabeth Anne Wreford Andersen, Brigitte Tonnoir, Naomi Fineberg

91 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Escitalopram in obsessive-compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study'. Together they form a unique fingerprint.

Medicine & Life Sciences